Co-Authors
This is a "connection" page, showing publications co-authored by Kathleen Moore and Robert Mannel.
Connection Strength
2.028
-
Is the NCI MATCH trial a match for gynecologic oncology? Gynecol Oncol. 2016 Jan; 140(1):161-6.
Score: 0.529
-
Research: An event or an environment? Gynecol Oncol. 2014 Sep; 134(3):441-2.
Score: 0.486
-
Adjuvant chemotherapy for the "oldest old" ovarian cancer patients: can we anticipate toxicity-related treatment failure in a vulnerable population? Cancer. 2009 Apr 01; 115(7):1472-80.
Score: 0.334
-
Ovarian cancer in the octogenarian: does the paradigm of aggressive cytoreductive surgery and chemotherapy still apply? Gynecol Oncol. 2008 Aug; 110(2):133-9.
Score: 0.315
-
A phase I trial of tailored radiation therapy with concomitant cetuximab and cisplatin in the treatment of patients with cervical cancer: A gynecologic oncology group study. Gynecol Oncol. 2012 Dec; 127(3):456-61.
Score: 0.106
-
Recent advances and clinical applications of deep learning in medical image analysis. Med Image Anal. 2022 07; 79:102444.
Score: 0.051
-
Experimental conditions influence the formation and composition of the corona around gold nanoparticles. Cancer Nanotechnol. 2021; 12(1):1.
Score: 0.047
-
Developing a new radiomics-based CT image marker to detect lymph node metastasis among cervical cancer patients. Comput Methods Programs Biomed. 2020 Dec; 197:105759.
Score: 0.046
-
Prediction of chemotherapy response in ovarian cancer patients using a new clustered quantitative image marker. Phys Med Biol. 2018 08 06; 63(15):155020.
Score: 0.040
-
Applying Quantitative CT Image Feature Analysis to Predict Response of Ovarian Cancer Patients to Chemotherapy. Acad Radiol. 2017 10; 24(10):1233-1239.
Score: 0.037
-
MICU1 drives glycolysis and chemoresistance in ovarian cancer. Nat Commun. 2017 05 22; 8:14634.
Score: 0.037